Verapamil Market

Verapamil?is used to treat?high blood pressure. Lowering?high blood pressure?helps prevent strokes,?heart attacks, and?kidney?problems. Verapamil belongs to a class of drugs known as?calcium?channel blockers. It works by relaxing?blood?vessels so blood can flow more easily.Verapamil is also used to prevent?chest pain?(angina). It may help to increase your ability to?exercise?and decrease how often you may get angina attacks. Verapamil is also used to control your?heart rate?if you have a fast/irregular heartbeat (such as?atrial fibrillation). It helps to lower the?heart rate, helping you to feel more comfortable and increase your ability to?exercise.
Verapamil Market aims to provide a comprehensive presentation of the global market for Verapamil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Verapamil. Verapamil Market contains market size and forecasts of Verapamil in global, including the following market information:
Global Verapamil Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Verapamil Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Verapamil companies in 2022 (%)
The global Verapamil market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Verapamil include REPLEK FARM, Mylan, Abbott Laboratories, YUNGSHIN PHARM IND. CO. LTD and The Central Pharmaceutical CO.,Ltd.Tianjin, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Verapamil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Verapamil Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, by Type, 2022 (%)
Tablets
Capsules
Injection
Others
Global Verapamil Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
Global Verapamil Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Verapamil revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Verapamil revenues share in global market, 2022 (%)
Key companies Verapamil sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Verapamil sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
REPLEK FARM
Mylan
Abbott Laboratories
YUNGSHIN PHARM IND. CO. LTD
The Central Pharmaceutical CO.,Ltd.Tianjin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Verapamil, market overview.
Chapter 2: Global Verapamil market size in revenue and volume.
Chapter 3: Detailed analysis of Verapamil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Verapamil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Verapamil capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.